MyHAE

Curated by Signal

App providing medical information and diary for hereditary angioedema

Overview

myHAE app is developed by Shire Pharmaceuticals to educate patients with hereditary angioedema (HAE). The users can record the attacks of HAE along with information such as symptoms, triggers, location, timing, severity, impact, and treatments. Also provider medical information about HAE.

Key facts

Founded: 2016
Headquarters: United Kingdom
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Glowery
Digital telehealth and listing platform for aesthetic professionals and patients
Health TechnologyHereford, United Kingdom
HeadFloss
Provider of an online teleconsultation platform for multiple diseases
Health TechnologyLondon, United Kingdom
BodyProphet
Provider of an online fitness training platform for fitness enthusiasts
Health TechnologyManchester, United Kingdom

About MyHAE

What does MyHAE do?

myHAE app is developed by Shire Pharmaceuticals to educate patients with hereditary angioedema (HAE).

Where is MyHAE headquartered?

MyHAE is headquartered in United Kingdom.

When was MyHAE founded?

MyHAE was founded in 2016.

Which sector is MyHAE in?

MyHAE operates in Health Technology.

Who are MyHAE's competitors?

Companies similar to MyHAE include Glowery, HeadFloss, and BodyProphet.